Hematologic Oncology Update
This series bridges the gap between research and patient care by providing medical oncologists with access to important information on relevant advances in the treatment of hematologic malignancies.
Dr. Neil Love
Show overview
Hematologic Oncology Update has been publishing since 2023, and across the 3 years since has built a catalogue of 154 episodes. That works out to roughly 170 hours of audio in total. Releases follow a weekly cadence, with the show now in its 25th season.
Episodes typically run thirty-five to sixty minutes — most land between 51 min and 1h 5m — and the run-time is fairly consistent across the catalogue. None of the episodes are flagged explicit by the publisher. It is catalogued as a EN-language Science show.
The show is actively publishing — the most recent episode landed 1 weeks ago, with 35 episodes already out so far this year. The busiest year was 2025, with 56 episodes published. Published by Dr. Neil Love.
From the publisher
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
Latest Episodes
View all 154 episodesMultiple Myeloma — Year in Review Series on Relevant New Datasets and Advances
Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Roles of CAR T-Cell Therapy and Bispecific Antibodies
Myelofibrosis — Proceedings from a Webinar Held in Conjunction with the 2026 ASCO Annual Meeting
Chronic Lymphocytic Leukemia — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
For Oncology Nurses: Relapsed/Refractory Multiple Myeloma — Proceedings from the 2026 Annual ONS Congress
Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 1
Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 2
Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress
Novel Therapies for Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit
Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit
Multiple Myeloma — Fifth Annual National General Medical Oncology Summit
Chronic Lymphocytic Leukemia — Fifth Annual National General Medical Oncology Summit
Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit
Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances
Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson
S25 Ep 73Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review
Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.CME information and select publications here.
S25 Ep 72CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson
Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.CME information and select publications here.